Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions

Abbas, 1999, A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease, Hum. Mol. Genet., 8, 567, 10.1093/hmg/8.4.567 Blasko, 2000, Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes, Neurobiol. Dis., 7, 682, 10.1006/nbdi.2000.0321 Burns, 2009, Parkin promotes intracellular A{beta}1-42 clearance, Hum. Mol. Genet., 18, 3206, 10.1093/hmg/ddp258 Choi, 2001, Co-association of parkin and alpha-synuclein, NeuroReport, 12, 2839, 10.1097/00001756-200109170-00017 Chung, 2004, S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function, Science, 304, 1328, 10.1126/science.1093891 Darios, 2003, Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 De Groot, 2001, Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions, Brain, 124, 1635, 10.1093/brain/124.8.1635 de Vries, 2008, Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?, Free Radic. Biol. Med., 45, 1375, 10.1016/j.freeradbiomed.2008.09.001 Dong, 2001, Immune function of astrocytes, Glia, 36, 180, 10.1002/glia.1107 Dumont, 2009, Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease, FASEB J., 23, 2459, 10.1096/fj.09-132928 Encinas, 2005, Nitric oxide and multiple sclerosis, Curr. Neurol. Neurosci. Rep., 5, 232, 10.1007/s11910-005-0051-y Franklin, 1997, Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system, J. Neurosci. Res., 50, 337, 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3 Furuta, 1995, Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus, Am. J. Pathol., 146, 357 Garcia-Vallejo, 2006, Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes, J. Cell Physiol., 206, 203, 10.1002/jcp.20458 Gilgun-Sherki, 2004, The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy, J. Neurol., 251, 261, 10.1007/s00415-004-0348-9 Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 Gu, 2005, Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease., Cell Death Differ., 12, 1202, 10.1038/sj.cdd.4401705 Hasegawa, 2008, Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways, J. Neurochem., 105, 1700, 10.1111/j.1471-4159.2008.05277.x Henn, 2007, Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling, J. Neurosci., 27, 1868, 10.1523/JNEUROSCI.5537-06.2007 Holscher, 2005, Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies, Rev. Neurosci., 16, 181, 10.1515/REVNEURO.2005.16.3.181 Imai, 2000, Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity, J. Biol. Chem., 275, 35661, 10.1074/jbc.C000447200 Keller, 2000, Impaired proteasome function in Alzheimer's disease, J. Neurochem., 75, 436, 10.1046/j.1471-4159.2000.0750436.x Kitada, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416 Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol., 157, 267, 10.1016/S0002-9440(10)64537-3 Ledesma, 2002, Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress, J. Neurochem., 83, 1431, 10.1046/j.1471-4159.2002.01253.x Lee, 1991, A68: a major subunit of paired helical filaments and derivatized forms of normal Tau, Science, 251, 675, 10.1126/science.1899488 Lipton, 2007, Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders, Int. Rev. Neurobiol., 82, 1, 10.1016/S0074-7742(07)82001-0 Mirra, 1991, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 Moreira, 2008, Alzheimer disease and the role of free radicals in the pathogenesis of the disease, CNS. Neurol. Disord. Drug Targets, 7, 3, 10.2174/187152708783885156 Perry, 1987, Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains, Proc. Natl. Acad. Sci. U. S. A., 84, 3033, 10.1073/pnas.84.9.3033 Power, 2008, Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology, Acta Neuropathol., 115, 611, 10.1007/s00401-008-0373-3 Rosen, 2006, Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells, J. Biol. Chem., 281, 12809, 10.1074/jbc.M512649200 Schlossmacher, 2002, Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies, Am. J. Pathol., 160, 1655, 10.1016/S0002-9440(10)61113-3 Schreibelt, 2007, Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology, Brain Res. Rev., 56, 322, 10.1016/j.brainresrev.2007.07.005 Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 Shimura, 1999, Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients, Ann. Neurol., 45, 668, 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z Shimura, 2000, Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase, Nat. Genet., 25, 302, 10.1038/77060 Stichel, 2000, Parkin expression in the adult mouse brain, Eur. J. Neurosci., 12, 4181 Tamo, 2007, Parkin is expressed in vascular endothelial cells, Neurosci. Lett., 419, 199, 10.1016/j.neulet.2007.04.023 Tanaka, 2001, Parkin is linked to the ubiquitin pathway, J. Mol. Med., 79, 482, 10.1007/s001090100242 Trapp, 2008, Multiple sclerosis: an immune or neurodegenerative disorder?, Annu. Rev. Neurosci., 31, 247, 10.1146/annurev.neuro.30.051606.094313 Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 Van Der Valk, 2000, Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS, Neuropathol. Appl. Neurobiol., 26, 2, 10.1046/j.1365-2990.2000.00217.x Van Horssen, 2006, Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions, Neuropathol. Appl. Neurobiol., 32, 585, 10.1111/j.1365-2990.2006.00766.x Van Horssen, 2008, Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression, Free Radic. Biol. Med., 45, 1729, 10.1016/j.freeradbiomed.2008.09.023 Wang, 2005, Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function, Hum. Mol. Genet., 14, 3885, 10.1093/hmg/ddi413 Weller, 2000, Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease, Ann. N. Y. Acad. Sci., 903, 110, 10.1111/j.1749-6632.2000.tb06356.x Wilhelmus, 2005, Apolipoprotein E genotype regulates amyloid-beta cytotoxicity, J. Neurosci., 25, 3621, 10.1523/JNEUROSCI.4213-04.2005 Wilhelmus, 2006, Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains, Neuropathol. Appl. Neurobiol., 32, 119, 10.1111/j.1365-2990.2006.00689.x Wilhelmus, 2009, Small heat shock proteins associated with cerebral amyloid angiopathy of hereditary cerebral hemorrhage with amyloidosis (Dutch type) induce interleukin-6 secretion, Neurobiol. Aging, 30, 229, 10.1016/j.neurobiolaging.2007.06.001 Wilhelmus, M.M., Verhaar, R., Bol, J.G., van Dam, A.M., Hoozemans, J.J., Rozemuller, A.J., Drukarch, B., in press. Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2009.04.019. Williams, 2007, Astrocytes—friends or foes in multiple sclerosis?, Glia, 55, 1300, 10.1002/glia.20546 Witte, 2009, Enhanced number and activity of mitochondria in multiple sclerosis lesions, J. Pathol., 219, 193, 10.1002/path.2582 Xu, 2001, Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation, J. Cereb. Blood Flow Metab., 21, 702, 10.1097/00004647-200106000-00008 Zarate-Lagunes, 2001, Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes, J. Comp. Neurol., 432, 184, 10.1002/cne.1096